Letermovir Prophylaxis for CMV DNAemia/Disease after HLA-Mismatched HSCT: A Retrospective Real-World Analysis with Overlap Propensity Score Weighting.

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/41346254

Bor-Sheng Ko; Fei-Yuan Hsiao; Jia-Hau Liu; Ming Yao; Shu-Wen Lin; Xavier Cheng-Hong Tsai; Yee-Chun Chen; Yi-Che Huang

Dec 5, 2025